Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Inventory: 2010-2024

Historic Inventory for China Pharma Holdings (CPHI) over the last 15 years, with Dec 2024 value amounting to $2.8 million.

  • China Pharma Holdings' Inventory rose 9.71% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 9.71%. This contributed to the annual value of $2.8 million for FY2024, which is 26.46% down from last year.
  • Latest data reveals that China Pharma Holdings reported Inventory of $2.8 million as of FY2024, which was down 26.46% from $3.9 million recorded in FY2023.
  • In the past 5 years, China Pharma Holdings' Inventory ranged from a high of $3.9 million in FY2023 and a low of $2.8 million during FY2024.
  • Moreover, its 3-year median value for Inventory was $2.9 million (2022), whereas its average is $3.2 million.
  • As far as peak fluctuations go, China Pharma Holdings' Inventory soared by 31.01% in 2023, and later declined by 26.46% in 2024.
  • China Pharma Holdings' Inventory (Yearly) stood at $3.7 million in 2020, then decreased by 20.44% to $2.9 million in 2021, then remained steady at $2.9 million in 2022, then skyrocketed by 31.01% to $3.9 million in 2023, then fell by 26.46% to $2.8 million in 2024.